The G2/M regulator 14-3-3sigma prevents apoptosis through sequestration of Bax
about
Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer14-3-3zeta mediates resistance of diffuse large B cell lymphoma to an anthracycline-based chemotherapeutic regimenMicroarray Analysis Reveals Increased Transcriptional Repression and Reduced Metabolic Activity but Not Major Changes in the Core Apoptotic Machinery during Maturation of Sympathetic Neurons.Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarraysProtein kinase Cepsilon interacts with Bax and promotes survival of human prostate cancer cells14-3-3 Interacts directly with and negatively regulates pro-apoptotic BaxIdentification of 14-3-3zeta as a protein kinase B/Akt substrate14-3-3 proteins--an updateThe role of epigenetic inactivation of 14-3-3sigma in human cancer14-3-3theta protects against neurotoxicity in a cellular Parkinson's disease model through inhibition of the apoptotic factor BaxNotch-activated signaling cascade interacts with mitochondrial remodeling proteins to regulate cell survivalAnalysis of 14-3-3sigma expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma.Proteomic screen in the simple metazoan Hydra identifies 14-3-3 binding proteins implicated in cellular metabolism, cytoskeletal organisation and Ca2+ signallingAberrant overexpression of an epithelial marker, 14-3-3sigma, in a subset of hematological malignanciesCooperative effect of p21Cip1/WAF-1 and 14-3-3sigma on cell cycle arrest and apoptosis induction by p14ARF.14-3-3sigma Modulates pancreatic cancer cell survival and invasiveness14-3-3gamma induces oncogenic transformation by stimulating MAP kinase and PI3K signaling.Role of 14-3-3σ in poor prognosis and in radiation and drug resistance of human pancreatic cancers.Aberrant cell cycle reentry in human and experimental inclusion body myositis and polymyositisThe cell cycle-regulated protein human GTSE-1 controls DNA damage-induced apoptosis by affecting p53 function.Apoptosis induced by 1,3,6,7-tetrahydroxyxanthone in Hepatocellular carcinoma and proteomic analysis.Muscarinic receptor activation protects cells from apoptotic effects of DNA damage, oxidative stress, and mitochondrial inhibitionReversible epigenetic regulation of 14-3-3σ expression in acquired gemcitabine resistance by uhrf1 and DNA methyltransferase 1.DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism.Proteomic analysis of differentially expressed proteins in vitamin C-treated AGS cells.Higher expression levels of 14-3-3sigma in ductal carcinoma in situ of the breast predict poorer outcome.Quantitative proteomic analysis of mitochondria from human ovarian cancer cells and their paclitaxel-resistant sublinesDynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes.Stratifin accelerates progression of lung adenocarcinoma at an early stage.14-3-3 proteins: do they have a role in human cancer?14-3-3γ regulates cell viability and milk fat synthesis in lipopolysaccharide-induced dairy cow mammary epithelial cells.14-3-3σ regulation of and interaction with YAP1 in acquired gemcitabine resistance via promoting ribonucleotide reductase expression.p53 signaling is involved in leptin-induced growth of hepatic and breast cancer cells.Determinants of 14-3-3σ protein dimerization and function in drug and radiation resistance.14-3-3sigma, the double-edged sword of human cancersAcute Hypoxic Stress Affects Migration Machinery of Tissue O2-Adapted Adipose Stromal Cells.Costunolide and dehydrocostuslactone combination treatment inhibit breast cancer by inducing cell cycle arrest and apoptosis through c-Myc/p53 and AKT/14-3-3 pathway.Endoplasmic reticulum stress sensitizes cells to DNA damage-induced apoptosis through p53-dependent suppression of p21(CDKN1A).Quantitative proteomic dissection of a native 14-3-3ε interacting protein complex associated with hepatocellular carcinoma.Significance of Wild-Type p53 Signaling in Suppressing Apoptosis in Response to Chemical Genotoxic Agents: Impact on Chemotherapy Outcome.
P2860
Q24298526-B1AEB460-010D-4701-BCA0-0AC73DFFC6F9Q24658236-82AE0088-5CDE-4D6E-884E-2CA15F0149E0Q27319928-1D590824-55B0-4BDB-B21E-0DFA77511AFBQ28185685-3F9F1464-B7E9-4623-BE57-4509A24269A2Q28206601-154A7649-FE6B-4D52-8371-16AB4C3A1FA6Q28214507-2C6DEFA6-E217-4A73-B9A7-88109F3C06ABQ28214915-A57B072A-F504-4524-B462-A933CED209D8Q28247242-4A8EEB83-87FE-47C6-A529-21558A739B04Q28247253-10FEBEF4-12AC-462A-A23E-3E07986D36C1Q28742388-49FE326B-8F69-49C5-A6C9-E4205FA8F655Q30494554-B957AD34-1E99-40F1-8D54-AD78ABC1EB58Q30977955-36D91AE0-ED8D-4D53-9259-1C582492E0EDQ33291681-9E170DD6-D3D5-438A-A60D-236BE74D6D06Q33307070-00E73005-F704-4668-A15D-9B1F23E674D4Q33370904-CF879791-A16E-4530-8D27-CB00BBB32A4CQ33388611-867DE899-2C36-481F-8E7A-706E4BDAC79CQ33632327-0EFFE3FF-B5BF-4664-BD3E-208B76207BF1Q33735346-EA2C8DED-09A1-4BEB-B400-06FE178D04CEQ33784450-A0B6E456-CA93-403D-86F7-A4C8FF3E4881Q34197362-3DAA1B66-06A9-4D93-8FB2-88B22C8C187BQ34275495-D010F5E2-2675-4BDA-9C16-5EE082F8C3E3Q34338754-71E54A3A-87CE-4E3E-94F6-101FEABC4A24Q34360074-ACCB876F-0D6C-4755-8C20-4482900270FCQ34773102-E015A8DA-DD18-497D-82A5-F47122F9CD45Q34997759-ABEC68D5-15C7-465D-A7A5-B885CAA51D40Q35207321-79D53203-4820-48EF-888E-1DBD862F0846Q35649272-BD9FCD42-6701-4AAA-9272-4B2A224E5F3FQ35787179-44DD7F7A-B8E6-4E5A-B3C3-675C6829C2CBQ35899417-4CE196D2-68BC-494D-8298-E9EB745FBBB5Q36429571-69AEC792-13B0-441E-9591-62473BDB0EEEQ36741864-B91F6E07-65BE-41D4-AC1B-2E912A21653EQ37109577-C2F18675-EA4F-4CAA-B513-7BD81E83DC7CQ37239773-5DD5222B-E306-4ED7-8AC2-01196E5B9AA3Q37272059-41C4B024-7A35-412E-9941-124B5A3293BAQ37427444-722D1E29-C768-4B35-94FA-C82880973B43Q37578720-C9AA1BB7-BF6F-4E54-B4B4-8AE2A1B7A37CQ37602110-D1A3F0E5-F36F-453C-988E-372A49C0EB51Q38949749-BDCA0DC7-DAE4-4F63-9CE8-75C4AE18DFF4Q39040945-F8AC0FCA-0561-4139-B6A6-D0FB7F5DD531Q39269601-3FD53F5E-3D49-42A0-92B1-36023E47947D
P2860
The G2/M regulator 14-3-3sigma prevents apoptosis through sequestration of Bax
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
The G2/M regulator 14-3-3sigma prevents apoptosis through sequestration of Bax
@ast
The G2/M regulator 14-3-3sigma prevents apoptosis through sequestration of Bax
@en
The G2/M regulator 14-3-3sigma prevents apoptosis through sequestration of Bax
@en-gb
The G2/M regulator 14-3-3sigma prevents apoptosis through sequestration of Bax
@nl
type
label
The G2/M regulator 14-3-3sigma prevents apoptosis through sequestration of Bax
@ast
The G2/M regulator 14-3-3sigma prevents apoptosis through sequestration of Bax
@en
The G2/M regulator 14-3-3sigma prevents apoptosis through sequestration of Bax
@en-gb
The G2/M regulator 14-3-3sigma prevents apoptosis through sequestration of Bax
@nl
prefLabel
The G2/M regulator 14-3-3sigma prevents apoptosis through sequestration of Bax
@ast
The G2/M regulator 14-3-3sigma prevents apoptosis through sequestration of Bax
@en
The G2/M regulator 14-3-3sigma prevents apoptosis through sequestration of Bax
@en-gb
The G2/M regulator 14-3-3sigma prevents apoptosis through sequestration of Bax
@nl
P2093
P2860
P921
P3181
P356
P1476
The G2/M regulator 14-3-3sigma prevents apoptosis through sequestration of Bax
@en
P2093
B Verdoodt
H Hermeking
P2860
P304
P3181
P356
10.1074/JBC.M106427200
P407
P577
2001-11-30T00:00:00Z